Table 3.
Best response of von Hippel–Lindau lesions by RECIST after sunitinib treatment
Lesion type | No. of lesions | Best response, n (%) |
||
Partial response | Stable disease | Progressive disease | ||
Hemangioblastoma | 21 | 0 | 19 (91) | 2 (9) |
Renal cell carcinoma | 18 | 6 (33) | 10 (67) | 2 (10) |
Renal cyst | 9 | 0 | 9 (100) | 0 |
Retinal angioma | 7 | 0 | 7 (100) | 0 |
Pancreatic NETs | 5 | 0 | 5 (100) | 0 |
Pancreatic cyst | 3 | 0 | 3 (100) | 0 |
NETs, neuroendocrine tumors.